So, fever is not always bad
Research published in Plastic and Reconstructive Surgery demonstrates that topical glutathione treatment in ischemic wound models significantly reduces oxidative stress and reestablishes the matrix metalloproteinase-1/tissue inhibitor of metalloproteinase-1 (MMP-1/TIMP-1) ratio, enabling adequate extracellular matrix production and reepithelization
This is not technically true
This approach is: More stable and shelf-friendly than isolated R-ALA Easier and more cost-effective to produce The form used in most clinical studies particularly those on diabetic neuropathy and metabolic support15 16 Some early research suggests R-ALA on its own may be more easily absorbed or better tolerated in sensitive individuals.17 18 Because R-ALA is more bioavailable, it spends less time in the stomach, moving more quickly into the intestines where absorption occurs
DNA maintenance*
Their inherent properties, including low systemic toxicity, site-specific delivery, and the capacity to penetrate biofilm matrices, enable improved local drug concentration and reduce recurrence rates [205]